Clinical Investigation and Molecular Forms of Family Disease of Varicose
Genetic Study of Varicose Disease by Sequencing Exome
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
La Roche sur Yon, France, 85000
- La Roche sur Yon Hospital
-
Nantes, France, 44093
- Nantes Univesrity Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Any patient consultant the Medicine Vascular Surgery for varicose veins of the lower limbs as part of a manifesto family context
- Varices Presence in at least one family member
- Written consent
Exclusion Criteria:
- Patients who are unable to sign or who refuse to sign an informed consent
- Subjects aged less than 25 years, due to the low penetrance of varicose disease that age.
- Secondary veins at a post-thrombotic disease (suspected by the examination and confirmed by Doppler ultrasonography of the deep venous system)
- Venous angiodysplasia or secondary varicose arteriovenous fistulas.
Study Plan
How is the study designed?
Design Details
- Observational Models: Family-Based
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
genetic abnormalities segregating with the presence of varicose veins in the informative families recruited.
Time Frame: year 4
|
year 4
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
genotype/phenotype relationship
Time Frame: year 4
|
improving knowledge of the genotype / phenotype based on genes identified in different families.
|
year 4
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Marc-Antoine Pistorius, PU-PH, Nantes university hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RC12_0142
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.